Skip to main content
. 2018 Jun 26;18:793. doi: 10.1186/s12889-018-5693-1

Table 3.

Baseline characteristics of 300 participants enrolled in the Run4Love study

Total (n = 300) Intervention (n = 150) Control (n = 150)
Age in years, median (Q1,Q3) 27.5 (24.5, 31.3) 27.4 (24.3, 31.1) 27.8 (24.6, 32.2)
Sex, % men 92.3 94.7 90.0
BMI, median (Q1,Q3) 20.1 (18.6, 21.7) 20.2 (18.7, 21.9) 19.9 (18.6, 21.3)
Education, % > high school 60.7 65.3 65.0
Homosexual/bisexual/uncertain,% 81.7 86.7 76.7
Married, % 12.7 12.0 13.3
Employed, % 83.7 82.0 85.3
Daily expenses, % affordable 85.0 86.0 84.0
Infection period in years,
Median (Q1,Q3)
1.7 (0.6, 3.7) 1.7 (0.6,4.0) 1.8 (0.6,3.6)
CES-D [0–60],
Median (Q1,Q3)
23.0 (19.0, 28.0) 23 (19.0, 28.0) 23 (19.0, 27.0)
PHQ-9 depression [0–27]
Median (Q1,Q3)
10.0 (7.0, 13.0) 10.0 (7.0, 12.8) 10.0 (7.0, 13.0)
GPAQ physical activity (METs),
% ≥600
43.3 43.3 43.3
HIV-related quality of life [24–120], Mean ± Standard deviation 77.0 ± 9.2 77.4 ± 9.0 76.6 ± 9.4
GSES Self efficacy [10–40],
Median (Q1,Q3)
23.0 (20.0, 27.2) 23.0 (20.0, 28.0) 23.0 (20.0, 27.0)
Perceived stress [0–40],
Median (Q1,Q3)
20 (18, 23) 20 (17, 22) 20 (18, 23)
HIV-related Stigma [14–56],
Median (Q1,Q3)
38.0 (32.0, 42.0) 37.0 (32.0, 42.0) 38.0 (34.0, 42.0)
Positive coping [0–36],
Median (Q1,Q3)
18 (14, 22) 18 (14, 21) 18 (13.2, 22)
Negative coping [0–24],
Median (Q1,Q3)
12 (9, 15) 12 (9, 15) 12 (9, 15)
CD4, median (Q1,Q3) 413 (304, 534) 416 (309, 536) 405 (303, 522)